ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 19 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $36,007,000 | +57.7% | 19,800,000 | +17.9% | 2.80% | +34.0% |
Q2 2017 | $22,837,000 | +52.1% | 16,800,000 | +60.0% | 2.09% | +36.9% |
Q1 2017 | $15,012,000 | +149.5% | 10,500,000 | +110.0% | 1.53% | +80.9% |
Q3 2016 | $6,018,000 | +647.6% | 5,000,000 | +513.5% | 0.85% | +318.8% |
Q3 2015 | $805,000 | -22.4% | 815,000 | 0.0% | 0.20% | -1.0% |
Q2 2015 | $1,037,000 | +0.4% | 815,000 | 0.0% | 0.20% | +14.6% |
Q1 2015 | $1,033,000 | -80.3% | 815,000 | -81.9% | 0.18% | -64.2% |
Q3 2013 | $5,254,000 | +176.1% | 4,500,000 | +125.0% | 0.50% | +148.5% |
Q2 2013 | $1,903,000 | – | 2,000,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 12,000,000 | $12,525,000 | 2.19% |
Mohican Financial Management, LLC | 4,900,000 | $5,090,000 | 1.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 23,000,000 | $23,978,000 | 1.24% |
QVT Financial LP | 9,000,000 | $9,428,000 | 0.55% |
WOLVERINE ASSET MANAGEMENT LLC | 13,250,000 | $13,880,000 | 0.28% |
ADVENT CAPITAL MANAGEMENT /DE/ | 19,919,000 | $20,824,000 | 0.26% |
DINSMORE CAPITAL MANAGEMENT CO/NJ | 500,000 | $522,000 | 0.21% |
Citadel Advisors | 18,500,000 | $19,384,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 8,500,000 | $8,829,000 | 0.02% |
CREDIT AGRICOLE S A | 2,181,000 | $2,266,000 | 0.01% |